Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Abbott Laboratories 12.593.
Gilead Sciences vs Abbott Laboratories: Revenue Comparison
Gilead Sciences (GILD) and Abbott Laboratories (ABT) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 58.0% for Abbott Laboratories. Gilead Sciences's net margin is -134.5% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Abbott Laboratories.| Metric | Gilead Sciences | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $12.59B |
| Cost of Revenue | $1.58B | $5.29B |
| Gross Profit | $6.22B | $7.30B |
| Operating Income | $-10.39B | $1.78B |
| Net Income | $-10.50B | $928.00M |
| R&D Expense | $1.76B | $882.00M |
| Earnings Per Share | -$8.45 | $0.53 |
| Gross Margin | 79.8% | 58.0% |
| Operating Margin | -133.2% | 14.2% |
| Net Profit Margin | -134.5% | 7.4% |
| Free Cash Flow | $3.69B | $2.89B |
| Cumulative Free Cash Flow | $155.83B | $142.48B |
| Operating Cash Flow | $3.57B | $2.49B |
| Cash & Equivalents | $3.18B | $5.10B |